Elsevier

Cellular Immunology

Volume 276, Issues 1–2, March–April 2012, Pages 114-121
Cellular Immunology

Post-transcriptional down-regulation of Toll-like receptor signaling pathway in umbilical cord blood plasmacytoid dendritic cells

https://doi.org/10.1016/j.cellimm.2012.04.010Get rights and content

Abstract

Plasmacytoid dendritic cells (PDCs) from human umbilical cord blood (UCB) produce lower amounts of IFN-α upon TLR stimulation compared with adult counterparts. This difference may play a role in the low graft-versus-host disease rate after UCB transplantation and in the impaired immune response of the neonate to pathogens. Comparing UCB PDC to their adults counterparts, we found that they exhibited a mature surface phenotype and a normal antigen uptake. They upregulated costimulatory molecules upon activation, although with delayed kinetics. Protein, but not ARN, levels of TLR-9, MyD88, IRAK1 and IRF-7, involved in the TLR-9 signaling pathway were reduced. The expression levels of miR-146a and miR-155, known to be involved in the post-transcriptional down-regulation of immune responses, were higher. These data point out a post-transcriptional down-regulation of the TLR-9/IRF-7 signaling pathway in UCB PDC.

Highlights

► We reveal the post-transcriptional control of IFN-alpha production in cord blood. ► Cord blood plasmacytoid dendritic cells exhibit a profound defect in IFN-a production. ► This defect correlates with the lower expression of proteins within the TLR9 pathway. ► We also observed a higher expression of miR-146a and miR-155. ► Although, cord blood PDC are mature and differentiate in antigen-presenting cells.

Introduction

Allogeneic hematopoietic stem cell transplantation (HSCT) is widely used for treating hereditary and/or hematological conditions of both malignant and non-malignant origin. Umbilical cord blood (UCB) has been used as an alternative source of HSC in transplantation for patients without an HLA-matched related donor, with similar therapeutic success as compared with unrelated bone marrow transplantation [1], [2], [3], [4], [5]. Unlike transplantation with other sources of HSC, UCB transplantation is characterized by a low incidence and severity of graft-versus-host-disease (GvHD), caused by donor T-cells recognizing and reacting to host major and minor histocompatibility antigens [6]. Nonetheless, this low rate of acute GvHD is not associated with a higher rate of leukemia relapse, indicating that graft-versus-leukemia (GvL) mechanisms are effective despite the lower alloreactivity [1], [7]. This contrasts with HSCT using other stem cell sources where increasing the GvL effect is associated with increased GvHD, and it indicates that UCB cells have unique immune properties that allow for allogeneic tolerance while preserving anti-tumoral activity.

Dendritic cells (DCs) capture, process and present antigens to T lymphocytes to induce immunity or tolerance [8]. Both host and donor DC participate in the initiation and the maintenance of GvHD following HSCT: host DC by presenting host-derived antigens to donor-T cells [6], [9], and graft-derived DC by maintaining and expanding alloreactive CD8+ T cells [9], [10], [11]. Several subtypes of DC, namely myeloid DC (mDC), plasmacytoid DC (PDC) and CD14−/lowCD16+ dendritic cells are present in UCB [12], [13]. Functional differences have been described between adult and neonatal DC subsets that may account for some of the unique immune properties of UCB cells [12], [14], [15], [16]. PDC are of particular interest because of their ability to induce either Th1 or Th2-dependent T cell cytotoxic responses and to induce tolerance through regulatory T cell (Treg) differentiation, depending on their environment [17]. It was even shown in a mouse model of hematopoietic transplantation that PDC can enhance the GvL activity of donor T cells without increasing GvHD, reminiscent of what is observed following UCB transplantation [18]. Further characterization of the immune properties of UCB PDC may therefore shed light on the unique immune properties of UCB, and open new avenues for improving UCB transplantation outcome.

PDC selectively express Toll-like receptors 7 and 9 (TLR-7 and TLR-9), which are localized in the endosomal–lysosomal compartment and recognize unmethylated CpG motifs on viral RNA and DNA [19]. Upon activation by TLR-ligands, adult PDC rapidly secrete massive amounts of type I interferons (IFN) as well as chemokines that allow for the recruitment and the activation of immune cells. This rapid and massive IFN response is due to the constitutively high level of expression of the IRF-7 transcription factor, which is phosphorylated and translocated to the nucleus upon activation of the TLR-7 or TLR-9 signaling pathways. PDC then undergo maturation to fully differentiated antigen-presenting cells and up-regulate the expression of T cell co-stimulatory molecules [20]. Type I IFN production is highly regulated by a set of positive and negative feedback loops as well as by cell surface receptors coupled with immunoreceptor tyrosine-based activation motifs (ITAMs) [21]. In addition, the post-transcriptional regulation of TLR-signaling pathway molecules by microRNA miR-146a [22], [23], [24], [25] and miR-155 [26] has been described, including molecules implicated in the control of type I IFN production [22], [27], [28]. MicroRNAs are small non-coding RNAs that suppress gene expression by binding to partially complementary sequences of mRNAs and inhibiting their translation into protein or accelerating their degradation [29].

CB PDC produce much less type I IFN upon activation by viral antigens or TLR-ligands [30], [31], [32], resembling tolerogenic PDC that were described in some tumor environments [33], [34], [35]. Here we examined the immune properties of UCB PDC at the cellular and molecular levels and compared them with adult PDC. Our results reveal that the lower IFNα production by UCB PDC is not due to immaturity but rather could be the result of a down regulation of TLR signaling molecules at the post-transcriptional level. Accordingly, we observed increased levels of miR-146a and miR-155 in UCB PDC as compared with adult PDC.

Section snippets

Blood and bone marrow samples

Cord blood samples were provided by the Research Cord Blood Bank of the CHU Sainte-Justine, in partnership with the public Cord Blood Bank administered by Héma-Québec. Cord blood units were harvested in sodium citrate collection packs by umbilical vein puncture after normal delivery of full-term healthy neonates. Adult peripheral blood samples were collected in heparinized tubes from healthy volunteers. Femoral heads from patients who undergone a total hip replacement surgery were used as a

Differentiation phenotype of UCB PDC

Three stages of differentiation can be distinguished by cell surface marker expression within the HLA-DR+ CD123hi PDC population in human bone marrow. The most immature stage of differentiation (stage I) is characterized by CD34 expression and low CD45 expression. Stage II cells express lower CD34 levels and higher CD45, and stage III cells are CD34 negative CD45hi [38]. We compared these differentiation stages in adult blood and UCB in order to determine the differentiation stage of UCB PDC.

Discussion

The present report explored UCB PDC phenotype and function to get new insights into the mechanisms of higher tolerance to alloantigens of UCB cells. UCB PDC exhibit a fully differentiated surface phenotype, uptake antigens and up-regulate co-stimulatory molecules upon activation, although with delayed kinetics. Their lower IFN-α response is associated with a post-transcriptional down-regulation of TLR-9 signaling pathway proteins. This down-regulation is in line with an increased expression of

Acknowledgments

This work was supported by the Fonds de Recherche en Santé du Québec and the Fondation Charles-Bruneau. Emily Charrier is a fellow of The Cole Foundation and the Fondation du CHU Sainte-Justine/Fondation des Etoiles. We thank Hugo Morin and Dr. Isabelle Louis at the Research Cord Blood Bank of CHU Sainte-Justine for providing cord blood units; Danièle Gagné (Institut de Recherche en Immunologie et Cancer, Université de Montréal) for cell sorting; Laurent Knafo for technical assistance in

References (54)

  • M.A. Nahid et al.

    MiR-146a is critical for endotoxin-induced tolerance. Implication in innate immunity

    J. Biol. Chem.

    (2009)
  • M.A. Lindsay

    MicroRNAs and the immune response

    Trends Immunol.

    (2008)
  • D.P. Bartel

    MicroRNAs: target recognition and regulatory functions

    Cell

    (2009)
  • D. De Wit et al.

    Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns

    Blood

    (2004)
  • E. Hermann et al.

    Human fetuses are able to mount an adultlike CD8 T-cell response

    Blood

    (2002)
  • A.H. Zarnani et al.

    Microenvironment of the feto-maternal interface protects the semiallogenic fetus through its immunomodulatory activity on dendritic cells

    Fertil. Steril.

    (2008)
  • K.D. Taganov et al.

    MicroRNAs and immunity: tiny players in a big field

    Immunity

    (2007)
  • V. Rocha et al.

    Pediatric related and unrelated cord blood transplantation for malignant diseases

    Bone Marrow Transpl.

    (2009)
  • V. Rocha et al.

    Searching for alternative hematopoietic stem cell donors for pediatric patients

    Bone Marrow Transpl.

    (2008)
  • J.H. Dalle et al.

    Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow

    Bone Marrow Transpl.

    (2004)
  • V. Rocha et al.

    Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and international bone marrow transplant registry working committee on alternative donor and stem cell sources

    N. Engl. J. Med.

    (2000)
  • J. Banchereau et al.

    Dendritic cells and the control of immunity

    Nature

    (1998)
  • W.D. Shlomchik et al.

    Prevention of graft versus host disease by inactivation of host antigen-presenting cells

    Science

    (1999)
  • C.C. Matte et al.

    Donor APCs are required for maximal GVHD but not for GVL

    Nat. Med.

    (2004)
  • A. Encabo et al.

    The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation

    Transfusion

    (2007)
  • F. Willems et al.

    Phenotype and function of neonatal DC

    Eur. J. Immunol.

    (2009)
  • J.M. Li et al.

    Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation

    J. Immunol.

    (2009)
  • Cited by (23)

    • Roles of microRNA in the immature immune system of neonates

      2018, Cancer Letters
      Citation Excerpt :

      Neonatal pDCs, in general, produce lower amounts of IFN-α upon TLR stimulation compared with their adult counterparts. Considering the higher levels of miR-146a and miR-155 in neonatal pDCs and their negative regulatory roles in TLR-dependent inflammatory responses, miR-146a and miR-155 were suggested to suppress IFN-α production in neonatal PDCs by Charrier E et al. [76]. Furthermore, a previous functional validation assay reported that the miR-155-5p expression level in neonatal pDCs was higher in the resting state but lower after CpG ODN stimulation [73].

    • Impaired interferon-alpha production by plasmacytoid dendritic cells after cord blood transplantation in children: Implication for post-transplantation toll-like receptor ligand-based immunotherapy

      2014, Biology of Blood and Marrow Transplantation
      Citation Excerpt :

      pDC-impaired function is more likely related to the stem cell source itself. Indeed, we and others have shown that pDCs present in CB are characterized by the combination of an absence of IFN-α production with normal upregulation of T cell costimulatory molecules upon TLR-9 stimulation [29,30]. Furthermore, it has recently been shown that IFN-α production is impaired in infant mice [31].

    View all citing articles on Scopus
    View full text